The overexpression of HER2 receptor in breast cancer alongside lungs, ovary and gastric/gastroesophageal cancers plays a major role in the angiogenic process and makes HER2 an important target in cancer therapy [114]. The gene discussed is ERBB2; the disease is breast cancer.